These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29403933)

  • 1. Isolation and characterization of a degradation product in leflunomide and a validated selective stability-indicating HPLC-UV method for their quantification.
    Saini B; Bansal G
    J Pharm Anal; 2015 Jun; 5(3):207-212. PubMed ID: 29403933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
    Bansal G; Singh R; Saini B; Bansal Y
    J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultraviolet-photodiode array and high-performance liquid chromatographic/mass spectrometric studies on forced degradation behavior of glibenclamide and development of a validated stability-indicating method.
    Bansal G; Singh M; Jindal KC; Singh S
    J AOAC Int; 2008; 91(4):709-19. PubMed ID: 18727528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride.
    Bansal G; Singh M; Jindal KC; Singh S
    J Pharm Biomed Anal; 2008 Nov; 48(3):788-95. PubMed ID: 18804934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability-indicating assay method for determination of actarit, its process related impurities and degradation products: Insight into stability profile and degradation pathways
    Abiramasundari A; Joshi RP; Jalani HB; Sharma JA; Pandya DH; Pandya AN; Sudarsanam V; Vasu KK
    J Pharm Anal; 2014 Dec; 4(6):374-383. PubMed ID: 29403903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC-MS/MS.
    Kushwah BS; Thummar MM; Yadav AS; Dhiman V; Samanthula G
    Biomed Chromatogr; 2023 Jan; 37(1):e5517. PubMed ID: 36200917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
    Bhardwaj SP; Singh S
    J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four new degradation products of doxorubicin: An application of forced degradation study and hyphenated chromatographic techniques.
    Kaushik D; Bansal G
    J Pharm Anal; 2015 Oct; 5(5):285-295. PubMed ID: 29403942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
    Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
    Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective separation and characterization of the stress degradation products of ondansetron hydrochloride by liquid chromatography with quadrupole time-of-flight mass spectrometry.
    Talluri MV; Keshari KK; Kalariya PD; Srinivas R
    J Sep Sci; 2015 May; 38(10):1625-32. PubMed ID: 25727389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC method development, validation, and impurity characterization of a potent antitumor indenoisoquinoline, LMP776 (NSC 725776).
    Wang J; Liu M; Yang C; Wu X; Wang E; Liu P
    J Pharm Biomed Anal; 2016 May; 124():267-273. PubMed ID: 26970596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC-MS/TOF and MS(n) studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Jan; 118():139-148. PubMed ID: 26547261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation Study on Sulfasalazine and a Validated HPLC-UV Method for its Stability Testing.
    Saini B; Bansal G
    Sci Pharm; 2014; 82(2):295-306. PubMed ID: 24959403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of degradation products and process-related impurity of sutezolid by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Guo K; Zhang T; Wang Y; Jin B; Ma C
    J Pharm Biomed Anal; 2019 May; 169():196-207. PubMed ID: 30877931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of four new degradation products of epirubicin through forced degradation, LC-UV, MSn and LC-MS-TOF studies.
    Kaushik D; Saini B; Bansal G
    J Chromatogr Sci; 2015; 53(10):1737-48. PubMed ID: 26162378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.